|
|
| Ankur Drugs & Pharma Limited |
|
Financials-Ankur Drugs & Pharma Limited| Sector: Bulk Drugs | | BSE:31683 | NSE:ANKURDRUGS | Bloomberg:MRP@IN | Reuters:ANDP.BO | | Market Lot: 1 | Face Value: 10 | ISIN Demat: INE238D01012 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
31-Dec-2012(3) |
31-Dec-2011(3) |
% Change |
| Sales of Products/Services |
360.65 |
384.24 |
-6.14 |
| Other Operating Income |
0.54 |
0.76 |
-28.95 |
| Other Income |
0.10 |
0.10 |
0.00 |
| Total Income |
361.29 |
385.09 |
-6.18 |
| Total Expenses |
376.39 |
465.17 |
-19.09 |
| OPBDIT |
-15.10 |
-80.08 |
-81.14 |
| Interest |
228.33 |
134.98 |
69.16 |
| Depreciation |
164.99 |
151.19 |
9.13 |
| Exceptional & Extraordinary Items |
0.00 |
0.00 |
-- |
| Prior Period Adjustments |
0.00 |
0.00 |
-- |
| Provision for Tax |
0.00 |
0.00 |
-- |
| After Tax Profit |
-408.42 |
-366.25 |
11.51 |
| Equity Capital |
193.42 |
193.42 |
0.00 |
| Reserves |
0.00 |
0.00 |
-- |
| Notes to Accounts |
Click here |
Click here |
|
|
| As on( Months ) |
31-Mar-07(12) |
|
31-Mar-06(12) |
|
31-Mar-05(12) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
2764.04 |
99.98 |
1354.39 |
99.96 |
785.80 |
99.96 |
| Operating Income (OI) |
2764.50 |
100.00 |
1354.87 |
100.00 |
786.10 |
100.00 |
| OPBDIT |
413.45 |
14.96 |
220.17 |
16.25 |
131.06 |
16.67 |
| OPBDT |
329.72 |
11.93 |
179.77 |
13.27 |
93.50 |
11.89 |
| OPBT |
303.87 |
10.99 |
154.19 |
11.38 |
72.68 |
9.25 |
| Non-Operating Income |
0.60 |
0.02 |
-0.05 |
-0.00 |
0.14 |
0.02 |
| Extraordinary/Prior Period |
3.27 |
0.12 |
-0.47 |
-0.04 |
-14.78 |
-1.88 |
| Tax |
32.93 |
1.19 |
13.87 |
1.02 |
8.36 |
1.06 |
| Profit after tax(PAT) |
274.81 |
9.94 |
139.80 |
10.32 |
49.67 |
6.32 |
| Cash Profit |
300.65 |
10.88 |
165.38 |
12.21 |
70.49 |
8.97 |
| Dividend-Equity |
19.02 |
0.69 |
14.25 |
1.05 |
9.50 |
1.21 |
|
| As on |
31-Mar-07 |
|
31-Mar-06 |
|
31-Mar-05 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
595.12 |
15.64 |
411.44 |
26.34 |
387.72 |
52.38 |
| Net Block |
487.59 |
12.81 |
329.89 |
21.12 |
331.17 |
44.74 |
| Capital WIP |
2029.75 |
53.34 |
656.13 |
42.00 |
86.81 |
11.73 |
| Investments |
0.16 |
0.00 |
0.06 |
0.00 |
0.06 |
0.01 |
| Inventory |
475.74 |
12.50 |
245.56 |
15.72 |
144.77 |
19.56 |
| Receivables |
744.11 |
19.56 |
283.50 |
18.15 |
153.11 |
20.68 |
| Other Current Assets |
67.86 |
1.78 |
47.07 |
3.01 |
24.29 |
3.28 |
| Balance Sheet Total(BT) |
3805.20 |
100.00 |
1562.20 |
100.00 |
740.22 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
105.55 |
2.77 |
95.00 |
6.08 |
95.00 |
12.83 |
| Reserves |
616.85 |
16.21 |
190.71 |
12.21 |
66.58 |
8.99 |
| Total Debt |
2775.39 |
72.94 |
1113.21 |
71.26 |
477.98 |
64.57 |
| Creditors and Acceptances |
170.39 |
4.48 |
54.06 |
3.46 |
22.66 |
3.06 |
| Other current liab/prov. |
137.02 |
3.60 |
109.22 |
6.99 |
78.00 |
10.54 |
| Balance Sheet Total(BT) |
3805.20 |
100.00 |
1562.20 |
100.00 |
740.22 |
100.00 |
|
| As on |
31-Mar-07 |
31-Mar-06 |
31-Mar-05 |
| OPBIT/Prod.cap.empl.(%) |
26.41 |
26.20 |
19.95 |
| PBIT/Cap. Employed (%) |
26.67 |
26.13 |
17.29 |
| PAT/Networth (%) |
38.04 |
48.93 |
30.74 |
| Tax/PBT (%) |
10.70 |
9.02 |
14.41 |
| Total Debt/Networth (x) |
3.84 |
3.90 |
2.96 |
| Long Term Debt/Networth (x) |
1.88 |
1.49 |
0.86 |
| PBDIT/Finance Charges (x) |
4.98 |
5.44 |
3.10 |
| Current Ratio (x) |
4.19 |
3.53 |
3.20 |
| RM Inventory (days consumption) |
73.94 |
83.63 |
84.17 |
| FG inventory (days cost of sales) |
1.35 |
0.94 |
0.39 |
| Receivables (days gross sales) |
97.19 |
69.91 |
63.88 |
| Creditors (days cost of sales) |
26.45 |
17.39 |
12.63 |
| Op. curr. assets (days OI) |
170.00 |
155.00 |
150.00 |
|
|
Financials